2[2]The Heart Outcome Prevention Evaluation study investigators.Effects of an anagiotension-converting-enzyme inhibitor,ramipril on cardiovascular events in high-risk patients.N Eng J Med,2000,342:145-153
3[3]UK Prospective Diabetes Study Group.Uk Prospective Diabetes Study(UKPDS).Study design,progress and performance.Diabetologia,1991,34:877-890
4[4]World Health Organization.Obesity:Preventing and Managing the Global Epidemic.Geneva:WHO,1998
5[8]Puska P.The North Karelia Project:Nearly 20 years of successful prevention of CVD in Finland.Hygie,1992,9:23-28